Business Information
The group's principal activities are to manufacture and formulate supplemental and medicinal products using proprietary processes. The group focuses on new product research to combine biotechnology and Chinese medical technology to capture the increasing demand for traditional Chinese medicines and health supplements. The group owns and operates several plants in addition to a large capacity soybean peptide manufacturing plant. Soybean peptides are used widely in general food and health food products, sports foods, medicines, the fermentation industry and environmental protection applications. These are easily absorbed by the body and can lower blood pressure and blood fat levels, enhance immunity, lower cholesterol, prevent cardiac and brain blood vessel diseases and inhibit the growth of tumors. During the year the group acquired bestkey international ltd & harbin three bioengineering limited.
|
|
Name |
Title
|
Email
|
| Shujun Liu | Chmn., CEO | N/A | | Yanchun Li | Dir., Acting CFO, COO, Sec. | N/A | | Baiqing Zhang | Dir. | N/A | | Binsheng Li | Dir., Chief Accounting and Finance Officer | N/A | | Cosimo Patti | Dir. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 110,182 | 29,201 | | 2005 | 54,733 | 13,426 | | 2004 | 31,967 | 7,771
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
